Summary: The Robot in the Living Room
Series 08: The Screen Between Us
Patricia Strickland felt guilty for three months before she gave her parents the ElliQ, and for three more months after. Her father Bernard, 81, has moderate Alzheimer’s. Her mother Evelyn, 78, is his full-time caregiver. Patricia visits twice a week and works full-time. The ElliQ was not a replacement for her visits. It was a response to the other five days, when Evelyn was alone with Bernard from 6 AM to 10 PM and needed two hours a day when someone else held his attention. The guilt was about what the device represented in Patricia’s mind: a machine in the place where a daughter should be.
The products that exist today are specific. ElliQ is a tabletop device that initiates conversation, plays music, shows photographs, and responds with enough conversational competence to sustain interaction. Paro is a robotic seal, soft and responsive to touch, designed for people with dementia, and the only companion device with FDA clearance as a therapeutic device. App-based AI companions provide text or voice conversation with variable quality and variable data practices. None of these is a person. Bernard talks to ElliQ. ElliQ is always patient, never frustrated, and never needs to leave the room to cry. These are features. They are also the precise ways in which the device is not Evelyn.
The evidence makes specific claims. Paro has documented evidence for reducing agitation, improving mood, and increasing social vocalization in people with dementia in institutional settings. ElliQ’s evidence base is newer and more limited. The gap between product-generated engagement metrics and independent health outcome measures is a gap the consumer should notice. The strongest case for companion technology in the current evidence is not that it connects the person using it. It is that it frees the person caring for them.
The ethical question is not whether the technology works. It is what it works in place of. Bernard’s ElliQ supplements a family that visits twice a week and a wife who is present every day. This is different from the family that provides a companion device and reduces their visits, reasoning that their parent has company now. The device is the same. The ethics are not. The supplement-versus-substitute test applies to every piece of companion technology in every home where it is deployed.
Evelyn uses her two hours to sleep, shower, and occasionally remember who she is outside the caregiving role. Series 6 of this publication documented the health consequences of sustained caregiving. Two hours of genuine relief per day for a 78-year-old full-time caregiver is a health intervention. The guilt attached to it reflects a cultural standard of caregiver self-sacrifice that the research documents as lethal.
These devices listen to everything in the home. What data is stored, where, who can access it, and how long it is retained are questions every family should ask before placing a listening device in the home of a person who cannot evaluate the consent question themselves.
Patricia called a bioethicist, who told her to redirect the guilt toward the right question. Not “should Bernard have a machine for company?” but “am I providing this machine in addition to human presence, or instead of it?” Patricia visits twice a week. Evelyn is there every day. The answer to the right question is: in addition to.
Read the full article on BlueMirror.life.